-
公开(公告)号:US10314825B2
公开(公告)日:2019-06-11
申请号:US15903279
申请日:2018-02-23
Applicant: KOWA COMPANY, LTD.
Inventor: Mitsumasa Nakamura , Satoshi Kojima , Ryohei Tanigawa
IPC: A61K31/423 , A61P1/16 , A61K31/575
Abstract: The present invention relates to a pharmaceutical composition for the treatment of primary biliary cirrhosis (PBC), in which containing a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate thereof.